Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Alphabet Inc.
18.1% sales growth and 17.51% return on equity
Alphabet Inc. sales growth this year is anticipated to be 10.5% and 21.3% for next year.
Year-on-year quarterly revenue growth grew by 14%, now sitting on 171.7B for the twelve trailing months.
Alphabet Inc.'s sales growth for the next quarter is 18.1%. The company's growth estimates for the ongoing quarter and the next is 2.2% and 38.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.51%.
Alphabet Inc.'s Stock Top and Bottom Yearly Value
Alphabet Inc.'s stock is valued at $1,781.77 at 22:57 EST, below its 52-week high of $1,847.20 and way higher than its 52-week low of $1,013.54.
Alphabet Inc.'s Moving Average
Alphabet Inc.'s worth is higher than its 50-day moving average of $1,739.02 and way above its 200-day moving average of $1,561.83.2. Repligen Corporation
43.1% sales growth and 4.04% return on equity
Repligen Corporation sales growth this year is anticipated to be 30.1% and 28.6% for next year.
Year-on-year quarterly revenue growth grew by 35.4%, now sitting on 327.09M for the twelve trailing months.
Repligen Corporation's sales growth for the next quarter is 43.1%. The company's growth estimates for the current quarter and the next is 55% and 9.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.04%.
Repligen Corporation's Stock Top and Bottom Yearly Value
Repligen Corporation's stock is valued at $180.90 at 22:57 EST, way below its 52-week high of $212.55 and way higher than its 52-week low of $78.41.
Repligen Corporation's Moving Average
Repligen Corporation's value is under its 50-day moving average of $186.11 and way above its 200-day moving average of $152.50.3. DexCom, Inc.
21.7% sales growth and 20.42% return on equity
DexCom, Inc. sales growth this year is expected to be 29.4% and 21.9% for next year.
Year-on-year quarterly revenue growth grew by 26.4%, now sitting on 1.82B for the twelve trailing months.
DexCom, Inc.'s sales growth for the next quarter is 21.7%. The company's growth estimates for the ongoing quarter and the next is a negative 20% and 13.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.42%.
DexCom, Inc.'s Stock Top and Bottom Yearly Value
DexCom, Inc.'s stock is valued at $347.71 at 22:57 EST, way below its 52-week high of $456.23 and way higher than its 52-week low of $182.07.
DexCom, Inc.'s Moving Average
DexCom, Inc.'s value is higher than its 50-day moving average of $340.70 and way below its 200-day moving average of $389.63.4. The Community Financial Corporation
12.4% sales growth and 7.81% return on equity
The Community Financial Corporation sales growth this year is expected to be 12.5% and a negative 0.8% for next year.
Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 56.01M for the twelve trailing months.
The Community Financial Corporation's sales growth for the next quarter is 12.4%. The company's growth estimates for the current quarter and the next is a negative 11% and 80.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.81%.
The Community Financial Corporation's Stock Top and Bottom Yearly Value
The Community Financial Corporation's stock is valued at $26.75 at 22:57 EST, way below its 52-week high of $36.23 and way higher than its 52-week low of $17.50.